Invention Grant
- Patent Title: Therapeutic inhibitory compounds
-
Application No.: US14800631Application Date: 2014-12-30
-
Publication No.: US10266515B2Publication Date: 2019-04-23
- Inventor: Andrew McDonald , Shawn Qian
- Applicant: LifeSci Pharmaceuticals, Inc.
- Applicant Address: BB Bridgetown, St. Michael
- Assignee: LIFESCI PHARMACEUTICALS, INC.
- Current Assignee: LIFESCI PHARMACEUTICALS, INC.
- Current Assignee Address: BB Bridgetown, St. Michael
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2014/072851 WO 20141230
- International Announcement: WO2015/103317 WO 20150709
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D413/14 ; A61K31/4709 ; A61K31/4725 ; A61K31/44 ; C07D405/14 ; C07D401/10 ; C07D401/12 ; C07D409/14 ; C07D471/04 ; C07D487/04
Abstract:
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.
Public/Granted literature
- US20180170906A1 THERAPEUTIC INHIBITORY COMPOUNDS Public/Granted day:2018-06-21
Information query
